Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 26.92%7.3B | 2.34%23.7B | -2.55%17.11B | -2.48%11.57B | -3.99%5.75B | 2.68%23.16B | 6.17%17.56B | 3.34%11.87B | 6.44%5.99B | 21.47%22.55B |
| Operating income | 26.92%7.3B | 2.34%23.7B | -2.55%17.11B | -2.48%11.57B | -3.99%5.75B | 2.68%23.16B | 6.17%17.56B | 3.34%11.87B | 6.44%5.99B | 21.47%22.55B |
| Cost of sales | ---- | -4.08%-17.59B | ---- | -10.93%-8.91B | ---- | -5.88%-16.9B | ---- | -7.60%-8.03B | ---- | -5.33%-15.97B |
| Operating expenses | 7.76%-4.19B | -4.08%-17.59B | -7.21%-13.26B | -10.93%-8.91B | -10.09%-4.54B | -5.88%-16.9B | -9.95%-12.36B | -7.60%-8.03B | -5.28%-4.12B | -5.33%-15.97B |
| Gross profit | 156.60%3.12B | -2.36%6.11B | -25.79%3.85B | -30.56%2.66B | -35.04%1.21B | -5.06%6.25B | -1.85%5.19B | -4.58%3.83B | 9.07%1.87B | 93.25%6.59B |
| Selling expenses | -18.85%-20.37M | -35.74%-113.9M | -19.00%-56.37M | -12.13%-36.14M | -7.60%-17.14M | -8.98%-83.91M | -6.50%-47.37M | -11.19%-32.23M | -21.53%-15.93M | -34.44%-77M |
| Administrative expenses | 2.88%-246.6M | -5.20%-1.19B | 12.82%-631.79M | 3.54%-494.42M | -3.79%-253.91M | -12.36%-1.13B | -3.90%-724.72M | -6.93%-512.55M | -6.20%-244.65M | -5.86%-1B |
| Research and development expenses | -600.16%-22.2M | ---- | -54.72%-23.01M | ---- | 50.77%-3.17M | ---- | 11.02%-14.87M | ---- | -55.73%-6.44M | ---- |
| Profit from asset sales | --123.68M | ---- | 103.89%194.16M | ---- | ---- | ---- | -76.30%95.23M | ---- | ---- | ---- |
| Impairment and provision | -935.35%-16.42K | -13,014.81%-466.48M | -3,709.30%-4.11M | -52.92%-3.45M | 140.93%1.97K | 100.30%3.61M | 99.11%-108.01K | 84.13%-2.26M | -207.97%-4.8K | -27,406.59%-1.21B |
| -Impairment of property, machinery and equipment | ---- | ---449.13M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.43M |
| -Other impairment is provision | -935.35%-16.42K | -580.40%-17.35M | -3,709.30%-4.11M | -52.92%-3.45M | 140.93%1.97K | 100.30%3.61M | 99.11%-108.01K | 84.13%-2.26M | -207.97%-4.8K | -27,374.13%-1.21B |
| Special items of operating profit | -14.81%318.93M | 145.83%1.1B | 15.16%1.15B | 89.04%355.96M | 35.37%374.38M | -42.55%446.11M | -0.14%999.09M | -70.27%188.3M | -3.84%276.56M | 154.84%776.54M |
| Operating profit | 154.06%3.26B | -1.01%5.44B | -18.30%4.42B | -28.51%2.48B | -30.27%1.28B | 8.27%5.49B | -7.24%5.41B | -15.83%3.48B | -6.09%1.84B | 87.60%5.07B |
| Financing income | 12.23%46.31M | ---- | -5.75%130M | ---- | -16.29%41.26M | ---- | -3.94%137.93M | ---- | 23.52%49.29M | ---- |
| Financing cost | 9.72%-313.21M | 5.14%-1.34B | 2.68%-1.01B | -1.72%-707.67M | 3.32%-346.95M | 3.72%-1.42B | 2.74%-1.04B | 7.83%-695.74M | 0.71%-358.87M | -47.87%-1.47B |
| Share of profits of associates | ---- | -9.75%487.56M | ---- | 2.39%266.68M | ---- | 18.06%540.23M | ---- | 22.59%260.47M | ---- | 44.13%457.6M |
| Share of profit from joint venture company | ---- | 22.43%774.34M | ---- | 4.95%365.84M | ---- | -13.39%632.5M | ---- | -2.32%348.58M | ---- | 0.69%730.29M |
| Special items of earning before tax | -106.24%-73.58K | ---- | 11.50%-8.7M | ---- | 566.32%1.18M | ---- | 18.89%-9.83M | ---- | -165.61%-252.99K | ---- |
| Earning before tax | 202.44%2.95B | 2.03%5.36B | -22.66%3.49B | -28.90%2.41B | -37.98%976.71M | 9.58%5.25B | -9.01%4.51B | -14.07%3.39B | 1.65%1.57B | 74.03%4.79B |
| Tax | ---- | -8.76%-933.52M | ---- | 43.37%-313.65M | ---- | 21.52%-858.31M | ---- | 35.16%-553.85M | ---- | -13.36%-1.09B |
| After-tax profit from continuing operations | 186.19%2.3B | 0.71%4.42B | -17.94%3.03B | -26.07%2.1B | -40.29%802.06M | 18.79%4.39B | -7.75%3.7B | -8.24%2.83B | 13.15%1.34B | 106.77%3.7B |
| Earning after tax | 186.19%2.3B | 0.71%4.42B | -17.94%3.03B | -26.07%2.1B | -40.29%802.06M | 18.79%4.39B | -7.75%3.7B | -8.24%2.83B | 13.15%1.34B | 106.77%3.7B |
| Minority profit | 30.55%122.11M | 10.73%385.82M | 29.19%311.52M | 20.49%201.4M | -1.43%93.54M | 9.58%348.44M | -18.05%241.14M | -14.02%167.15M | 3.92%94.89M | -2.82%317.99M |
| Profit attributable to shareholders | 206.74%2.17B | -0.15%4.04B | -21.22%2.72B | -28.99%1.89B | -43.25%708.53M | 19.65%4.04B | -6.93%3.46B | -7.85%2.67B | 13.92%1.25B | 131.32%3.38B |
| Basic earnings per share | 167.81%0.3977 | -2.51%0.8262 | -21.23%0.5707 | -28.99%0.3971 | -43.26%0.1485 | 19.65%0.8475 | -6.94%0.7245 | -7.84%0.5592 | 13.93%0.2617 | 131.17%0.7083 |
| Diluted earnings per share | 167.41%0.3971 | -2.51%0.8262 | -21.23%0.5707 | -28.99%0.3971 | -43.26%0.1485 | 19.65%0.8475 | -6.82%0.7245 | -7.72%0.5592 | 13.93%0.2617 | 131.47%0.7083 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | ShinWing Certified Public Accountants (Hong Kong) Limited | -- | -- | -- | ShinWing Certified Public Accountants (Hong Kong) Limited | -- | -- | -- | PwC |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.